The novel pathway for modulating intestinal Cl− secretion through the colonic CaSR may lead to new pharmaco-nutritional therapies for prevention or treatment of certain clinical diarrheal diseases (i.e., cholera and other cyclic nucleotide-associated diarrheal diseases). The gene discussed is CASR; the disease is diarrheal disease.